Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients

  • Published : 2015.12.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Tumor markers, designated as a broad group of substances produced by malignancies, could be in the form of biochemical substances, immunological substances, cell surface changes and genetic alterations. Cancer, a disorder of cellular behavior is characterized by alteration of serum glycoproteins. L-fucose, a hexose, which is the terminal sugar in most of the plasma glycoproteins, may be useful as a tumor marker for the detection, monitoring and prognostic assessment of malignancies. The aim of the study was to ascertain the role of serum fucose as a biomarker for early detection of oral cancer and to compare serum fucose levels in healthy controls, leukoplakia and oral cancer patients. Materials and Methods: The study included 60 (100.0%) subjects, who were grouped as 20 (33.3%) control subjects, 20 (33.3%) squamous cell carcinoma patients and 20 (33.3%) leukoplakia patients. Fucose estimation was done using UV-visible spectrophotometry based on the method as adopted by Winzler using cysteine reagent. The results were analyzed statistically using ANOVA with Bonferroni post hoc tests. Results: Results showed a high significance in serum fucose in oral squamous cell carcinoma (OSCC) and leukoplakia subjects compared to normal controls. There was a gradual increase in the values noted from control to leukoplakia and to squamous cell carcinoma. Conclusions: Estimation of serum fucose may be a reliable marker and can be used as an effective diagnostic biomarker in oral squamous cell carcinoma patients.

Keywords

References

  1. Abbasi MM, Esfahlan RJ, Monfaredan A, et al (2014). Oral and IV dosages of doxorubicin-methotrexate loaded-nanoparticles inhibit progression of oral cancer by downregulation of matrix methaloproteinase 2 expression in Vivo. Asian Pac J Cancer Prev, 15, 10705-11.
  2. Arya DB, Bhatnagar (1974). Evaluation of serum fucose level. Ind J Surg, 36, 224-8.
  3. Bathi RJ (1991). Evaluation of glycoproteins as prognosticators in head and neck malignancy. Cancer, 67, 135-140. https://doi.org/10.1002/1097-0142(19910101)67:1<135::AID-CNCR2820670124>3.0.CO;2-6
  4. Elkins, Rita MH (2003). Miracle sugars: the glyconutrient link to better health. pleasant grove, utah, USA: Woodland Publishing, 220.
  5. Fernandez-Rodriguez J, Paez de la Cadena M, Martinez-Zorzano VS, Rodriguez-Berrocal FJ (1997). Fucose levels in sera and in tumours of colorectal adenocarcinoma patients. Cancer Lett, 121, 147-53. https://doi.org/10.1016/S0304-3835(97)00343-1
  6. Gurudath S, Ganapathy KS, Sujatha D, et al (2012). Estimation of superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral leukoplakia and oral cancer - a comparative study. Asian Pac J Cancer Prev, 13, 4409-12. https://doi.org/10.7314/APJCP.2012.13.9.4409
  7. Hassona Y, Scully C, Almangush A, Baqain Z, Sawair F (2014). Oral potentially malignant disorders among dental patients: a pilot study in Jordan. Asian Pac J Cancer Prev, 15, 10427-31.
  8. Kadam CV, Katkam RV, Suryakar AN, Kumbar KM, Kadam DP (2011). Biochemical markers in oral cancer. Biomedical Res, 22, 76-80.
  9. Kanagi R (1997). Carbohydrate mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J, 14, 577-84. https://doi.org/10.1023/A:1018532409041
  10. Khovidhunkit SP, Buajeeb W, Sanguansin S, Poomsawat S, Weerapradist W (2008). Detection of human papillomavirus in oral squamous cell carcinoma, leukoplakia and lichen planus in Thai Patients. Asian Pac J Cancer Prev, 9, 771-5.
  11. Kimura Y, Fujieda S, Bayashi TT, et al (2000). Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma. Cancer let, 155, 163-168. https://doi.org/10.1016/S0304-3835(00)00423-7
  12. Krishna A, Singh RK, Singh S, et al (2014). Demographic risk factors, affected anatomical sites and clinicopathological profile for oral squamous cell carcinoma in a north indian population. Asian Pac J Cancer Prev, 15, 6755-60. https://doi.org/10.7314/APJCP.2014.15.16.6755
  13. Kumar S, Muniyandi M (2010). Tobacco use and oral leukoplakia: cross-sectional study among the gond tribe in madhya pradesh. Asian Pac J Cancer Prev, 16, 1515-8.
  14. Lotfi A, Mohammadi G, Tavassoli A, et al (2015). Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev, 16 , 1327-30. https://doi.org/10.7314/APJCP.2015.16.4.1327
  15. Mac Dougall SL, Schwarting GA, Parkinson D, Sullivan AK (1987). Increased fucosylation of glycolipids in a human leukaemia cell line (K562-Clone I) with decreased sensitivity to NK mediated lysis. Immunol, 62, 75-80.
  16. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in north-western and central asia - past, present and future. Asian Pac J Cancer Prev, 11, 17-32.
  17. Oliver RJ, MacDonald DG, Felix DH (2000). Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med, 29, 49-55. https://doi.org/10.1034/j.1600-0714.2000.290201.x
  18. Parwani RN, Parwani SR (2011). Serum fucose: a biomarker quantitative evaluation of serum fucose in oral squamous cell carcinoma patients. J Cancer Res Ther, 7, 143-7. https://doi.org/10.4103/0973-1482.82928
  19. Pindborg JJ (1981). Oral cancer and Precancer. First edition - Dorset Press, 12.
  20. Raval GN, Sainger RN, Rawal RM, et al (2002). Vitamin B12 and folate status in head and neck cancer. Asian Pac J Cancer Prev, 3, 155-62.
  21. Seibert FB, Seibert MV, Atno AJ, Campbell HW (1947). Variation in protein and polysaccharide content of sera in the chronic diseases, tuberculosis, sarcoidosis and carcinoma. J Clin Invest, 26, 90-102. https://doi.org/10.1172/JCI101794
  22. Sharma NC, Sur BK (1967). Serum fucose levels and sialic acid levels in Indian children and adults under normal and pathological conditions. Ind J Med Res, 55, 380-4.
  23. Shah M, Telang S, Raval G (2008). Serum fucosylation changes in oral cancer and oral precancerous conditions. Cancer, 113, 336-46. https://doi.org/10.1002/cncr.23556
  24. Shetlar MR, Foster JV, Kelly KH, et al (1947). The serum polysaccharide level in malignancy and other pathological states. Cancer Res, 9, 515-9.
  25. Silvia CRWD, Vasudevan DM, Prabhu KS (2001). Evaluation of serum glycoproteins in oral carcinoma. Indian J Clin Biochem, 16, 113-5. https://doi.org/10.1007/BF02867579
  26. Taneja N, Bathi JR, Praveen S, Bhat K (2009). Serum glycoproteins as prognosticator in oral cancer patients- A follow up study. Int J Bio-Med Sci, 8, 74-82.
  27. Tormey DC, Davis TE, Walkers PT (1982). Tumor markers in principles of cancer treatment. New York: Academic Press, .
  28. Tsuda H, Moore MA (2001). Cancer screening: a review with particular attention to areas for future international research efforts. Asian Pac J Cancer Prev, 3, 99-123.
  29. Wang JW, Ambros RA, Weber PB, Rusano TG (1995). Fucosyltransferase and alpha-L fucosidase activities and fucose levels in normal and malignant endometrial tissue. Cancer Res, 55, 3654-8.
  30. Winzler RJ (1955). In: Methods of biochemical analysis. Glick D, editor. Interscience Publishers Inc, New York, 279-377.
  31. Youakim A, Herscovics A (1985). Cell surface glycopeptides from human intestinal epithelial cell lines derived from normal colon and colon adenocarcinomas. Cancer Res, 45, 5505-11.

Cited by

  1. Glycosylation: a hallmark of cancer? vol.34, pp.2, 2017, https://doi.org/10.1007/s10719-016-9755-2